BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36291151)

  • 1. Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression.
    Lin TH; Chang SL; Khanh PM; Trang NTN; Liu SC; Tsai HC; Chang AC; Lin JY; Chen PC; Liu JF; Guo JH; Liu CL; Wu HC; Tang CH
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Apelin and Apelin Receptor Expression in Migration and Invasiveness of Colon Cancer Cells.
    PodgÓrska M; Pietraszek-Gremplewicz K; OlszaŃska J; Nowak D
    Anticancer Res; 2021 Jan; 41(1):151-161. PubMed ID: 33419808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.
    Zhu M; Zhang N; He S; Lui Y; Lu G; Zhao L
    FEBS Lett; 2014 Feb; 588(4):600-7. PubMed ID: 24440352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
    Sun W; Zu S; Shao G; Wang W; Gong F
    J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-106a-5p targets forkhead box transcription factor FOXC1 to suppress the cell proliferation, migration, and invasion of ectopic endometrial stromal cells via the PI3K/Akt/mTOR signaling pathway.
    Zhou X; Chen Z; Pei L; Sun J
    Bioengineered; 2021 Dec; 12(1):2203-2213. PubMed ID: 34082653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GAS5 Represses Osteosarcoma Cells Growth and Metastasis via Sponging MiR-203a.
    Wang Y; Kong D
    Cell Physiol Biochem; 2018; 45(2):844-855. PubMed ID: 29414815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.
    Zhu M; Zhang N; He S; Yan R; Zhang J
    Clin Exp Metastasis; 2016 Jun; 33(5):509-19. PubMed ID: 27142596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-151 regulates the growth, chemosensitivity and metastasis of human prostate cancer cells by targeting PI3K/AKT.
    Chen S; Ke S; Cheng S; Wu T; Yang Y; Liao B
    J BUON; 2020; 25(4):2045-2050. PubMed ID: 33099951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
    Li X; Zhou Q; Tao L; Yu C
    Oncol Rep; 2017 Sep; 38(3):1774-1782. PubMed ID: 28731196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
    Xu S; Ge J; Zhang Z; Zhou W
    Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X; Ren H; Zhang Y; Wang B; Ma H
    Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
    Hong BS; Ryu HS; Kim N; Kim J; Lee E; Moon H; Kim KH; Jin MS; Kwon NH; Kim S; Kim D; Chung DH; Jeong K; Kim K; Kim KY; Lee HB; Han W; Yun J; Kim JI; Noh DY; Moon HG
    Cancer Res; 2019 Apr; 79(7):1520-1534. PubMed ID: 30737233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 18. Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3.
    Jia J; Li F; Tang XS; Xu S; Gao Y; Shi Q; Guo W; Wang X; He D; Guo P
    Oncotarget; 2016 Jun; 7(25):37868-37881. PubMed ID: 27191265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression.
    Shen KH; Hung JH; Chang CW; Weng YT; Wu MJ; Chen PS
    Chem Biol Interact; 2017 Apr; 268():129-135. PubMed ID: 28283413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.